Zydus launches in U.S. MSN Labs generic of Bayer’s PAH drug

The two companies are the first to launch the product, which is a generic version of Bayer’s Adempas.
More news in Industry
IRDAI imposes ₹2 cr penalty on Star HealthJewellery demand remains resilient for Q3 despite gold price surge
U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in VizagGarment exporters urged to focus on financial disciple and have strategic foresight to capture orders